Cargando…
VHL-P138R and VHL-L163R Novel Variants: Mechanisms of VHL Pathogenicity Involving HIF-Dependent and HIF-Independent Actions
The von Hippel–Lindau (VHL) disease is an autosomal dominant cancer syndrome caused by mutations in the VHL tumor suppressor gene. VHL protein (pVHL) forms a complex (VBC) with Elongins B-C, Cullin2, and Rbx1. Although other functions have been discovered, the most described function of pVHL is to r...
Autores principales: | Mathó, Cecilia, Fernández, María Celia, Bonanata, Jenner, Liu, Xian-De, Martin, Ayelen, Vieites, Ana, Sansó, Gabriela, Barontini, Marta, Jonasch, Eric, Coitiño, E. Laura, Pennisi, Patricia Alejandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978939/ https://www.ncbi.nlm.nih.gov/pubmed/35388293 http://dx.doi.org/10.3389/fendo.2022.854365 |
Ejemplares similares
-
Playing Tag with HIF: The VHL Story
por: Leung, Sherri K., et al.
Publicado: (2002) -
VHL and Hypoxia Signaling: Beyond HIF in Cancer
por: Zhang, Jing, et al.
Publicado: (2018) -
HIF2a inhibitors for the treatment of VHL disease
por: Metelo, Ana Martins, et al.
Publicado: (2015) -
The VHL/HIF Axis in the Development and Treatment of Pheochromocytoma/Paraganglioma
por: Peng, Song, et al.
Publicado: (2020) -
Two sides to every story: the HIF-dependent and HIF-independent functions of pVHL
por: Li, Mingqing, et al.
Publicado: (2011)